Financhill
Back

Moderna 10K Form

Sell
37

MRNA
Moderna

Last Price:
78.23
Seasonality Move:
39.5%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MRNA News And Ratings

See the #1 stock for the next 7 days that we like better than MRNA

MRNA Financial Statistics

Sales & Book Value

Annual Sales: $18.88B
Cash Flow: $-1.74B
Price / Cash Flow: 0
Annual Sales: $35.32
Price / Book: 2.22

Profitability

EPS (TTM): -9.35000
Net Income (TTM): $-3.47B
Gross Margin: $13.46B
Return on Equity: -20.06%
Return on Assets: -14.77%

Moderna Earnings Forecast

Key Moderna Financial Ratios

  • The Gross Profit Margin over the past 29 years for MRNA is 71.31%.
  • The Selling, General & Administrative Expenses for MRNA have been equal to 6.00% of Gross Profit Margin.
  • The Research & Development expenses have been 17.46% of Revenue.
  • The Interest Expense is 0.35% of Operating Income.
  • The Net Earning history of MRNA is 44.30% of Total Revenues.
  • Per Share Earnings over the last 29 years have been positive in 14 years.

Moderna Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Healthcare
Current Symbol: MRNA
CUSIP: 60770K
Website: modernatx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 2.46
Quick Ratio: 2.22

Price-to-Earnings

Trailing P/E Ratio: 3.89
Forward P/E Ratio: 0

MRNA Technical Analysis vs Fundamental Analysis

Sell
37
Moderna (MRNA) is a Sell

Is Moderna a Buy or a Sell?

  • Moderna stock is rated a Sell
    The current Moderna [MRNA] share price is $78.18. The Score for MRNA is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.